Daily as of 4 Nov 16:00 ET
- Price
- between the two $11.42 vs 50 $13.57 / 200 $10.96
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 24 Dec 2025 · projected 21 bars out · tested 4 bars
BVS | Bioventus Inc. Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$11.42
+$0.47 (+4.34%)
Bioventus Inc. Class A (BVS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $13.33 vs 50 $10.27 / 200 $7.12
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 20 Jan 2025 · projected 4 bars out · tested 2 bars
4-hour as of 4 Nov 16:00 ET
- Price
- below both $11.42 vs 50 $13.55 / 200 $12.81
- Projection
- 💀Death cross estimated in 14 to 19 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 8 Jul 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Jul 2026 | 🟨Golden | 4-hour | 26 bars out | Not tested |
| 22 Jun 2026 | 💀Death | 4-hour | 26 bars out | 2 bar cross test |
| 24 Dec 2025 | 🟨Golden moderate | daily | 21 bars out | 4 bar cross test |
| 7 Nov 2025 | 🟨Golden | 4-hour | 5 bars out | Not tested |
| 16 Oct 2025 | 💀Death | 4-hour | 21 bars out | 4 bar cross test |
About BVS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall